Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) Q3 2022 Earnings Conference Call November 30, 2022 8:30 AM ET Company Participants Benjamin Thiele-Long - Director, Executive and Business Communications Ron Coughlin - Chief Executive Officer Brian LaRose - Chief Financial Officer Conference Call Participants Liz Suzuki - Bank of America Simeon Gutman - Morgan Stanley Peter Benedict - Baird Oliver Wintermantel - Evercore ISI Michael Lasser - UBS Chris Bottiglieri - BNP Paribas Steven Zaccone - Citi Seth ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an ...

Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) Q2 2022 Earnings Conference Call August 24, 2022 8:30 AM ET Company Participants Benjamin Thiele-Long - Director, Executive and Business Communications Ron Coughlin - Chairman & CEO Brian LaRose - CFO Conference Call Participants Kate McShane - Goldman Sachs Stephanie Wissink - Jefferies Anna Andreeva - Needham & Company Seth Basham - Wedbush Securities Steven Zaccone - Citi Simeon Gutman - Morgan Stanley Chris Bottiglieri - BNP Paribas Exane Elizabeth S ...

WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2022 UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39878 Petco Health and Wellness Company, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 81-1005932 (State o ...

PETCO FIRST QUARTER 2022 EARNINGS CALL May 24, 2022 SAFE HARBOR AND NON-GAAP MEASURES This Presentation contains "forward-looking statements" within the mearing of the Pivate Securities Litigation Reform Act of 1995 as contained in Section 274 of the Securit as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs plans, objectives, goals, strategies, tuture events or per underlying assumptions and other statements that are other than statements of his ...

Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) Q1 2022 Earnings Conference Call May 24, 2022 8:30 AM ET Company Participants Benjamin Thiele-Long - Director, Executive and Business Communications Ron Coughlin - Chairman & Chief Executive Officer Brian LaRose - Chief Financial Officer Conference Call Participants Peter Benedict - Robert W. Baird Seth Basham - Wedbush Elizabeth Suzuki - Bank of America Zach Fadem - Wells Fargo Kate McShane - Goldman Sachs Michael Lasser - UBS Oliver Wintermantel - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 29, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39878 Petco Health and Wellness Company, Inc. (Exact name of Registrant as specified in its Charter) Delaware 81-1005932 (State or oth ...

Financial Data and Key Metrics Changes - Full year 2021 revenue growth was 18%, translating to a 22% growth in adjusted EBITDA, reflecting the strength of the business model and operating leverage [11][63] - In Q4, net revenue reached $1.51 billion, up 13% year-over-year, with comparable sales growth of 14% [57] - Q4 adjusted EBITDA was $172 million, an increase of 16% from the prior year, and adjusted EPS improved by 65% to $0.28 [62] Business Line Data and Key Metrics Changes - Services and other grew 64% on a two-year basis and 31% year-over-year, benefiting from the expansion of membership and subscription programs [58] - Revenue from consumables increased by 29% on a two-year stack and 19% year-over-year [57] - The pharmacy business grew 66% year-over-year, indicating strong growth in both Rx food and prescriptions [34] Market Data and Key Metrics Changes - The company gained market share across digital and brick-and-mortar channels, with a notable increase in customer acquisition, adding nearly 800,000 net new customers in Q4 [19][29] - Digital revenue growth was 143% over two years, with a 25% increase year-over-year, showcasing strong performance in the digital space [29] Company Strategy and Development Direction - The company is evolving into a "Retail 3.0" player, leveraging omnichannel advantages and robust service offerings [9] - A transformational transaction to purchase the remaining stake in the Thrive hospital joint venture was announced, enhancing the company's veterinary services capabilities [22][54] - The focus remains on long-term above-market growth through unique ecosystem offerings and strategic growth initiatives [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to drive continued growth and market share gain in 2022, expecting net revenue of $6.15 billion to $6.25 billion [69] - Inflationary pressures were acknowledged, but the company has been effective in passing through input price increases without a material impact on unit volumes [60][84] - The company is committed to improving the lives of pets and pet parents, with significant community engagement initiatives [44][45] Other Important Information - The company ended 2021 with 1,433 Pet Care Centers in the U.S. and Puerto Rico, with plans to maintain a similar footprint in 2022 [65][66] - The company has a strong liquidity position, ending the quarter with $650 million, including cash and availability on the revolving credit facility [67] Q&A Session Summary Question: Pricing expectations within the full year top line guidance - Management noted that the pet industry is relatively immune to macroeconomic trends, with premiumization continuing to drive growth [75][76] Question: Impact of inflation on same-store sales increase - Inflation contributed a low single-digit impact to total comparable sales, with no elasticity impact observed [84] Question: Customer acquisition and performance of the 2020 cohort - The company added approximately 800,000 new customers in Q4, with strong performance across both online and brick-and-mortar channels [94][96] Question: Update on the Lowe's partnership - The partnership with Lowe's is seen as a significant opportunity to access new customers and enhance brand visibility [99][100] Question: Vital Care 2.0 potential - Management is optimistic about reaching one million customers for Vital Care, viewing it as a key driver for customer loyalty and spending [105][106]

| --- | --- | --- | |-------|---------------------|-------| | | | | | | Fourth Quarter 2021 | | Safe Harbor and Non-GAAP Measures This Presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs plans, objectives, goals, strategies, future events or performance and underlyi ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the quarterly period ended October 30, 2021 WASHINGTON, DC 20549 OR FORM 10-Q Securities registered pursuant to Section 12(b) of the Act: For the transition period from to Commission File Number: 001-39878 Petco Health and Wellness Company, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 81-1005932 (State or other jurisdiction of incor ...